Westfield Capital Management Co. LP Boosts Stock Position in Masimo Corporation $MASI

Westfield Capital Management Co. LP grew its holdings in Masimo Corporation (NASDAQ:MASI) by 7.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,522,049 shares of the medical equipment provider’s stock after buying an additional 102,799 shares during the quarter. Masimo accounts for 0.8% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 22nd largest position. Westfield Capital Management Co. LP’s holdings in Masimo were worth $197,958,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Global Retirement Partners LLC purchased a new stake in shares of Masimo in the fourth quarter valued at approximately $27,000. Rothschild Investment LLC increased its position in shares of Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares in the last quarter. Torren Management LLC purchased a new stake in shares of Masimo in the fourth quarter valued at approximately $35,000. Smartleaf Asset Management LLC increased its position in shares of Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 136 shares in the last quarter. Finally, Advisory Services Network LLC purchased a new stake in shares of Masimo in the third quarter valued at approximately $46,000. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Stock Up 0.1%

Shares of MASI opened at $178.90 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. Masimo Corporation has a one year low of $125.94 and a one year high of $179.00. The stock has a market capitalization of $9.37 billion, a price-to-earnings ratio of -16.97, a PEG ratio of 1.81 and a beta of 1.11. The stock has a 50 day moving average price of $178.43 and a 200 day moving average price of $159.18.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on MASI shares. Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Wells Fargo & Company upgraded Masimo to a “hold” rating in a research report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 price target on Masimo in a research report on Tuesday, February 17th. Finally, Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Nine investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Masimo currently has a consensus rating of “Hold” and a consensus price target of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.